Blackstone Minerals Ltd has updated its schedule for issuing shares under the Institutional Offer, now set for November 15, 2024, due to pending clearance of funds from ... For further insights into ...
Analyst Michael Ulz from Morgan Stanley reiterated a Buy rating on Dyne Therapeutics (DYN – Research Report) and keeping the price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback